Gilead asks FDA again to approve twice-a-year HIV-fighting drug By: San Francisco Business Times via Business Journals June 27, 2022 at 19:37 PM EDT The drug, called lenacapavir, was rejected by the FDA in February because of issues with the vials holding the injectable drug. Read More >>
